This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
MiPLA: Difference between revisions
>Unity Use "MiPLA" instead of "MIPLA". Added citation flags. |
>LockPicker Added legal situation in germany |
||
| Line 129: | Line 129: | ||
{{#ask: [[Category:MiPLA]][[Category:Experience]]|format=ul|Columns=1}} | {{#ask: [[Category:MiPLA]][[Category:Experience]]|format=ul|Columns=1}} | ||
Additional experience reports can be found here: | Additional experience reports can be found here: | ||
* [https://erowid.org/experiences/subs/exp_MiPLA.shtml Erowid Experience Vaults: MiPLA] | |||
*[https://erowid.org/experiences/subs/exp_MiPLA.shtml Erowid Experience Vaults: MiPLA] | |||
==Toxicity and harm potential== | ==Toxicity and harm potential== | ||
| Line 161: | Line 162: | ||
{{legalStub}} | {{legalStub}} | ||
MiPLA is not scheduled under the UN Convention on Psychotropic Substances. It is considered to exist in a legal grey area throughout most of the world, meaning that it might not be specifically illegal but individuals may still be charged for its possession under certain circumstances such as under analogue laws and with the intent to sell or consume. | MiPLA is not scheduled under the UN Convention on Psychotropic Substances. It is considered to exist in a legal grey area throughout most of the world, meaning that it might not be specifically illegal but individuals may still be charged for its possession under certain circumstances such as under analogue laws and with the intent to sell or consume. | ||
*'''Austria:''' MiPLA is technically not illegal but it may fall in the NPSG (Neue-Psychoaktive-Substanzen-Gesetz Österreich) as an analogue of LSD. {{citation needed}} | *'''Austria:''' MiPLA is technically not illegal but it may fall in the NPSG (Neue-Psychoaktive-Substanzen-Gesetz Österreich) as an analogue of LSD. {{citation needed}} | ||
*'''United States:''' MiPLA is not scheduled but may be considered to be an analogue of LSD, which would make it illegal to possess for human consumption under the Federal Analogue Act. | *'''Germany:''' MiPLA is controlled under the NpSG as of July 18, 2019.<ref>https://www.buzer.de/gesetz/12250/v224771-2019-07-18.htm</ref> <ref>https://www.gesetze-im-internet.de/npsg/anlage.html</ref> Production and import with the aim to place it on the market, administration to another person and trading is punishable. Possession is illegal but not penalized.<ref>https://www.gesetze-im-internet.de/npsg/__4.html</ref> | ||
*'''United States:''' MiPLA is not scheduled but may be considered to be an analogue of LSD, which would make it illegal to possess for human consumption under the Federal Analogue Act.{{citation needed}} | |||
==See also== | ==See also== | ||
*[[Responsible use]] | *[[Responsible use]] | ||
*[[Research chemical]] | *[[Research chemical]] | ||
| Line 173: | Line 177: | ||
==External links== | ==External links== | ||
* [https://en.wikipedia.org/wiki/Methylisopropyllysergamide MiPLA (Wikipedia)] | |||
* [https://isomerdesign.com/PiHKAL/explore.php?domain=tk&id=5327 MiPLA (TiHKAL / Isomer Design)] | *[https://en.wikipedia.org/wiki/Methylisopropyllysergamide MiPLA (Wikipedia)] | ||
*[https://isomerdesign.com/PiHKAL/explore.php?domain=tk&id=5327 MiPLA (TiHKAL / Isomer Design)] | |||
===Discussion=== | ===Discussion=== | ||
* [http://www.bluelight.org/vb/threads/784440-The-Small-amp-Handy-MiPLA-(Methylisopropyllysergamide)-Thread The Small & Handy MiPLA Thread (Bluelight)] | |||
*[http://www.bluelight.org/vb/threads/784440-The-Small-amp-Handy-MiPLA-(Methylisopropyllysergamide)-Thread The Small & Handy MiPLA Thread (Bluelight)] | |||
==Literature== | ==Literature== | ||
* Halberstadt, A. L., Klein, L. M., Chatha, M., Valenzuela, L. B., Stratford, A., Wallach, J., ... & Brandt, S. D. (2018). Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA). Psychopharmacology, 1-10. http://dx.doi.org/10.1007/s00213-018-5055-9 | |||
* [https://heffter.org/docs/hrireview/02/chap6.pdf Nichols, D. E. (2001). LSD and its lysergamide cousins. The Heffter Review of Psychedelic Research. Santa Fe, New Mexico: Heffter Research Institute, 80-87.] | *Halberstadt, A. L., Klein, L. M., Chatha, M., Valenzuela, L. B., Stratford, A., Wallach, J., ... & Brandt, S. D. (2018). Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA). Psychopharmacology, 1-10. http://dx.doi.org/10.1007/s00213-018-5055-9 | ||
*[https://heffter.org/docs/hrireview/02/chap6.pdf Nichols, D. E. (2001). LSD and its lysergamide cousins. The Heffter Review of Psychedelic Research. Santa Fe, New Mexico: Heffter Research Institute, 80-87.] | |||
==References== | ==References== | ||